Federal Register #2026-13364

DEA Regulatory Notice: Temporary Scheduling of Four Synthetic Opioids as Schedule I Substances

This notice from the Drug Enforcement Administration (DEA) announces a regulatory action regarding synthetic opioids: - Government Buyer: - Department of Justice, Drug Enforcement Administration (DEA) - Action: Regulatory notice of intent to temporarily place four synthetic opioids into Schedule I of the Controlled Substances Act - Substances affected: - 5,6-dichloro brorphine (SR14968) - 5,6-dichloro desmethylchlorphine (SR17018) - N-propionitrile chlorphine (cychlorphine) - Spirochlorphine (R6890) - No OEMs, vendors, or commercial products are involved, as this is not a procurement or solicitation - No products or services are being requested; the notice imposes regulatory controls and sanctions on the listed substances - Unique requirements: - The substances are being scheduled due to their high potential for abuse, lack of accepted medical use, and imminent hazard to public safety - The order will affect all activities related to these chemicals, including manufacture, distribution, import, export, research, and possession

Description

The Drug Enforcement Administration (DEA) is issuing a notice of intent to temporarily place four synthetic opioids—5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine—into Schedule I of the Controlled Substances Act. These substances have been identified in drug seizures and toxicology reports and pose an imminent hazard to public safety due to their high potential for abuse and lack of accepted medical use in treatment in the United States. The temporary scheduling order will impose regulatory controls and sanctions applicable to Schedule I substances. The notice is effective July 1, 2026, with the temporary scheduling order to be published on or after July 31, 2026.

View original listing